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The advantages of t he  use of 1 2 3 ~  over o t h e r  ,o~Tr. 
-A 1 
radio-isotopes f o r  c l i n i c a l  d i agnos t i c  procedures 
i n  nuclear  medicine, i ts s h o r t  h a l f - l i f e  (13.1 
hours) and the  s u i t a b i l i t y  of  i ts only emitted 
r a d i a t i o n  (159 keV y ray)  t o  e x i s t i n g  de t ec t ion  
methods, have been known f o r  many years .  3, 
In  s p i t e  of these  i d e a l  p rope r t i e s ,  however, i t  has 
no t  come i n t o  general  c l i n i c a l  use because of  t he  
complexity of i ts production v i a  p a r t i c l e  ac- 
c e l e r a t o r s  and r e s u l t i n g  high cos t .  A review 
of t he  various r eac t ion  mechanisms used t o  
produce 1 2 3 ~  is  provided by Sodd e t  a1.495) 
~ o s t  commercial supp l i e r s  of 1 2 3 ~  use low energy 
r eac t ions  (5 35 MeV) on expensive, i s o t o p i c a l l y  
enriched 1 2 2 ~ e  o r  1 2 4 ~ e  t a rge t s .  The p u r i t y  of  
t he  r e s u l t i n g  1231 depends on the  p u r i t y  of  t h e  
Te t a r g e t ,  t h e  primary contaminant being 1241, 
a b e t a  emi t t e r  wi th  a 4.2 day h a l f - l i f e .  
A program t o  develope an on-line f a c i l i t y  
Figure 2. 
f o r  t h e  production of an 1 2 3 ~  i so tope  f r e e  of  any 
o the r  r ad ioac t ive  contaminants v i a  t he  l2 7~ (p, 5n) 
B+ 12%e + 1231 has  begun using the  proton beam from 
t h e  Indiana Isochronous Cyclotron. The ob jec t ive  is  
t o  demonstrate t h a t  a pure 1 2 7 ~  "Liquid-Vapor" t a r g e t  
assembly u t i l i z i n g  a continuous helium gas flow 
generator  is n o t  only f ea s ib l e ,  bu t  has a h igher  
production r a t e  than o t h e r  t a r g e t s  using t h i s  reac t ion ,  
while y i e ld ing  a contaminant-free isotope.  I n  addi t ion ,  
i t  is  requi red  t h a t  t he  t a r g e t  assembly be usable f o r  
many i r r a d i a t i o n s  with no maintainance o r  re-charging, 
while being quickly and e a s i l y  placed i n t o  o r  out  of 
s e r v i c e  on t h e  beam l i n e  i n  t he  i so tope  production 
room. 
The cross  s ec t ion  f o r  t he  1271 (p,5n) 12%e re- 
a c t i o n  has  been measured by seve ra l  groups6)and is 
found t o  peak a t  about 57 MeV, a s  i l l u s t r a t e d  i n  
Figure 1. The 1 2 7 ~  (p, 3n) r eac t ion  cross  s e c t i o n  
is a l s o  shown and is  a poss ib l e  contaminant source,  
i.e., 125= . From these  da ta ,  t h e  ca l cu l a t ed  y i e l d  of 
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1 2 3 ~  using the  helium gas genera tor  method f o r  p o r t  t h e  iodine  and ~e~~~ vapors through a low 
c o l l e c t i o n  of t he  X e  i so topes  i s  given i n  Fig.  2. temperature p u r i f i c a t i o n  t r a p  (-800C) t o  remove t h e  
The r a t e  of 1 2 3 ~ e  growth during i r r a d i a t i o n  and radio iodines ,  and on t o  a c o l l e c t i o n  t r a p  opera ted  
ensuing decay,as we l l  a s  those  f o r  1 2 3 ~  a r e  a t  l i q u i d  n i t rogen temperatures. The t a r g e t  con- 
shown f o r  a t y p i c a l  6 hour i r r a d i a t i o n  period.  t a i n s  100 grams of 1 2 7 ~  i n i t i a l l y .  I n  i ts  s t a b l e  
For comparison purposes, t h e  y i e l d  of 1 2 3 ~  f o r  opera t ing  mode, t h e  vapors escaping from t h e  t a r g e t  
a 6 hour ba tch  i r r a d i a t i o n  of  1 2 7 ~  followed by volume, condense on the  cooled wa l l s  of  t h e  vapor- 
t h e  s epa ra t ion  of  t he  Xe i so topes  is shown. tube about one inch  above the  t a r g e t  and d r i p s  back 
Using our gas genera tor  system, described below, down i n t o  t h e  t a r g e t  volume. Thus, during i r r a d i a t i o n ,  
a production r a t e  of 16 mCi/pA h r  has  been the  amount of  iodine  a t  t he  l o c a t i o n  of t he  beam 
achieved, which is s l i g h t l y  b e t t e r  than the  r a t e  remains constant .  
experienced by other groups who made 1231 
using t h e  (p, 5n) r eac t ion .  39 7, 
A 1271 self-vapor cooled t a r g e t ,  a s  des- 
8 
cr ibed  by Blue e t  a l . ,  was b u i l t  and modified 
f o r  our  t e s t s .  A schematic of  t he  t a r g e t  and 
cold t r a p  system is shown i n  Figure 3. Pure 
iodine  is kept  i n  t he  l i q u i d  s t a t e  i n  t h e  t a r g e t  
by hea t ing  t h e  wa l l s  of t he  vapor tube t o  1100C. 
The wa l l s  above t h e  t a r g e t  volume a r e  water  cooled 
t o  prevent t h e  i od ine  from condensing out  of  t h e  
With a t a r g e t  th ickness  of  2.2 cm, 100 MeV pro- 
tons l o s e  55 MeV i n  t h e  t a r g e t .  Beam e x i t i n g  from 
t h e  t a r g e t  is co l l ec t ed  on a cu r r en t  reading beam 
s t o p  f o r  monitoring purposes. Inc iden t  protons of  
energy h igher  than 100 MeV a r e  used by the  placement 
of energy reducing f o i l s  i n  f r o n t  of  t he  t a r g e t  
assembly. Beam energies  a s  low a s  80 MeV may be used 
wi th  no apprec iable  con t r ibu t ion  of  t he  (p,3n) re- 
ac t ion .  
The t a r g e t  apparatus described above was used t o  
t a rge tvo lume .  H e l i u m g a s i s i n j e c t e d a t a s l o w  m a k e 1 2 3 ~ i n v a r i o u s a m o u n t s u p t o 1 6 m C i i n a 6 h r .  
r a t e  (4.5 cfm) a t  t he  top of  t he  tube t o  t rans-  s h i f t  wi th  a production r a t e  of 16 mCi/pA-hr. The 
pur i ty  of the  i so tope  was v e r i f i e d  by ana lys i s  of 
the  y-ray spec t r a ,  which showed only one y-ray 
a t  159 keV. The most l i k e l y  contaminant would be 
1 2 5 ~ ,  which is produced by a (p,3n) r eac t ion  on 
1271, and has a 35 keV y ray.  Background i n  t he  
observed spec t r a  would obscure a contamination 
of 2 0.01% l251, i f  present .  No 35 keV y ray was 
observed i n  t he  i so tope  produced using e i t h e r  
80 MeV o r  100 MeV protons. 
E f f o r t s  a r e  continuing t o  improve the  rugged- 
ness and r e u s a b i l i t y  of t he  t a r g e t  assembly, and 
t o  automate the  ex t r ac t ion  of t h e  iodine  from the  
co l l ec t ion  t r ap .  I n  addi t ion ,  e f f o r t s  a r e  being 
made t o  improve the  e f f i c i ency  of t he  ex t r ac t ion  
procedure, which now s tands  a t  about 75%. The 
production r a t e  quoted above is f o r  the  amount of 
1123 ex t r ac t ed  from the  t r a p  a f t e r  a given 
i r r a d i a t i o n  period.  
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Figure 4 .  1 2 3 ~  production s t a t i o n  i n  p lace  i n  
t h e  i so tope  production room. The 1271 t a r g e t  
i s  mounted i n  t he  HVEC c ros s  a t  t he  end of t he  
beamline. Target, He gas generator ,  and cold 
t r a p  f o r  impurity and Xe i so tope  co l l ec t ion  
a r e  v i s i b l e .  The e n t i r e  assembly is  mounted 
on a rollaway c a r t  f o r  easy i n s t a l l a t i o n  and 
removal from t h e  beamline. When the  t a r g e t  
s t a t i o n  is removed, a s ec t ion  of beamline is  
i n s t a l l e d  and connected t o  t h e  beam dump 
whose opening is v i s i b l e  a t  t he  upper l e f t .  
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